Comparison of efficacy between long-acting beta 2-agonists (formoterol fumarate) and leukotriene-receptor antagonists (montelukast) as add-on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma

Sasikala Kumaravel; Kingston Rajiah; Suchandra Sen

doi:10.4103/2045-080x.132649

Comparison of efficacy between long-acting beta 2-agonists (formoterol fumarate) and leukotriene-receptor antagonists (montelukast) as add-on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma

Sasikala Kumaravel
, Kingston Rajiah
, Suchandra Sen

Biomedical Sciences Research

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Arch Pharma Pract
DOIs	https://doi.org/10.4103/2045-080x.132649
Publication status	Published (in print/issue) - 2014

Access to Document

10.4103/2045-080x.132649

Cite this

@article{f4f8d2420c9b4e3a9d20be69b7f8537d,

title = "Comparison of efficacy between long-acting beta 2-agonists (formoterol fumarate) and leukotriene-receptor antagonists (montelukast) as add-on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma",

author = "Sasikala Kumaravel and Kingston Rajiah and Suchandra Sen",

year = "2014",

doi = "10.4103/2045-080x.132649",

language = "English",

journal = "Arch Pharma Pract",

issn = "2045-080X",

}

Comparison of efficacy between long-acting beta 2-agonists (formoterol fumarate) and leukotriene-receptor antagonists (montelukast) as add-on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma. / Kumaravel, Sasikala; Rajiah, Kingston; Sen, Suchandra.
In: Arch Pharma Pract, 2014.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Comparison of efficacy between long-acting beta 2-agonists (formoterol fumarate) and leukotriene-receptor antagonists (montelukast) as add-on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma

AU - Kumaravel, Sasikala

AU - Rajiah, Kingston

AU - Sen, Suchandra

PY - 2014

Y1 - 2014

U2 - 10.4103/2045-080x.132649

DO - 10.4103/2045-080x.132649

M3 - Article

SN - 2045-080X

JO - Arch Pharma Pract

JF - Arch Pharma Pract

ER -